Evaluation of MTT assay for measurement of emodin-induced cytotoxicity

Xiangfei Wang1, Junbo Ge, Keqiang Wang

  • 1Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.

Insights

Emodin interferes with the MTT assay

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay is a common method for measuring cell viability and cytotoxicity.
  • Factors like colored substances and cell volume can affect MTT assay accuracy.
  • Emodin, a compound with potential therapeutic applications, may interfere with MTT assay measurements due to its properties.

Purpose of the Study:

  • To investigate the impact of emodin on the accuracy of the MTT assay.
  • To evaluate the reliability of a modified MTT assay for measuring emodin-induced cytotoxicity in vascular smooth muscle cells.

Main Methods:

  • Culturing vascular smooth muscle cells in M199 medium.
  • Measuring optical density of emodin and formazan using spectrophotometry.
  • Assessing emodin's absorption spectrum in various solvents.
  • Evaluating dose- and time-dependent cytotoxicity induced by emodin.

Main Results:

  • Emodin's absorption spectrum is solvent-dependent, with water-containing solvents causing a red shift and increased overlap with formazan absorption.
  • Emodin forms formazan in a dose-dependent manner, partially suppressed by serum.
  • Emodin induces cytotoxicity in a time- and dose-dependent manner.
  • Emodin alters the accuracy of the standard MTT assay.

Conclusions:

  • Emodin can interfere with the accuracy of the MTT assay.
  • A modified MTT assay remains a valuable tool for quantifying emodin-induced cytotoxicity despite potential interferences.

Related Concept Videos